Felicia Cosman
About
In The Last Decade
Felicia Cosman
202 papers receiving 16.5k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Orthopedics and Sports Medicine 11.8k
- Oncology 8.1k
- Molecular Biology 6.0k
- Surgery 3.3k
- Pathology and Forensic Medicine 2.3k
Countries citing papers authored by Felicia Cosman
This map shows the geographic impact of Felicia Cosman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felicia Cosman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felicia Cosman more than expected).
Fields of papers citing papers by Felicia Cosman
This network shows the impact of papers produced by Felicia Cosman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felicia Cosman. The network helps show where Felicia Cosman may publish in the future.
Co-authorship network of co-authors of Felicia Cosman
This figure shows the co-authorship network connecting the top 25 collaborators of Felicia Cosman. A scholar is included among the top collaborators of Felicia Cosman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felicia Cosman. Felicia Cosman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 23 | |
| 3 | 10 | |
| 4 | 26 | |
| 5 | 15 | |
| 6 | 31 | |
| 7 | 14 | |
| 8 | 129 | |
| 9 | relationship between total hip BMD T-score and incidence of nonvertebral fracture with up to 10 years of Denosumab (DMAB) treatment | 1 |
| 10 | Relationship between total hip BMD T-score and incidence of nonvertebral fracture with up to 8 years of denosumab treatment | 5 |
| 11 | Percentage of women achieving non-osteoporotic BMD T-scores at the spine and hip over 8 years of denosumab treatment | 1 |
| 12 | 3 | |
| 13 | 107 | |
| 14 | 125 | |
| 15 | 90 | |
| 16 | 39 | |
| 17 | 186 | |
| 18 | Rationale and design of the MOTION study (monthly oral therapy with ibandronate for osteoporosis intervention). | 2 |
| 19 | Osteoporosis : an evidence-based guide to prevention and management | 19 |
| 20 | Biochemical Markers in the Diagnosis and Treatment of Osteoporosis | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.